Delivery Order SPE2DB22D3301-SPE2DB24FZ2VY

Award Date 8/13/24
Potential Completion Date 8/14/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,905.51, is for the delivery of 4,567,873,176 units of Gabapentin 600 mg tablets in lots of 100. The contract is not designated as a set-aside and is considered an open competition award. It is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
This is a firm fixed-price delivery order worth $2,362.56 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of gabapentin 600 mg tablets. The order has a completion date of September 11, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as a primary vehicle for providing a wide range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 600mg Gabapentin tablets, a medication commonly used to treat nerve pain and other conditions. The contract has a ceiling value of $1,079.88 and runs through October 25, 2024. It is a firm fixed-price contract, with no set-aside designation indicated. Amerisourcebergen holds a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the provision of 4,564,801,733 Gabapentin 800 mg tablets. The contract is a delivery order with a firm fixed price of $1,103.84 and a period of performance through June 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 800 mg gabapentin tablets. The contract has a ceiling value of $2,012.40 and an ultimate completion date of July 26, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leveraging its extensive supply chain network. This contract is part of a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gabapentin 600 mg tablets, a medication used to treat certain types of nerve pain. The contract has a ceiling value of $1,284.80 and is a firm fixed-price delivery order, with a period of performance running through April 11, 2025. There is no set-aside designation for this award....
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred ninety-three dollars and sixteen cents to Amerisourcebergen Drug Corporation for 4561815490 gabapentin 800 mg tablets. As the prime contractor, Amerisourcebergen will deliver ninety tablets to a facility in Conshohocken, Pennsylvania by August 16, 2023 to fulfill requirements under the Agency's pharmaceutical supply chain program. No subcontractors or set aside designations were indicated. The order...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with an award value of $10,563.87, is for the delivery of 4,562,266,736 units of gabapentin 250 mg/5 ml solution in 470 ml containers. The contract has a completion date of September 22, 2023 and is a Firm Fixed Price Delivery Order contract. While the original solicitation is not provided, the award indicates that no...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $1,693.44, was issued by the Defense Logistics Agency (DLA) under a Delivery Order contract. The contract is for the supply of Gabapentin 300 mg capsules, a pharmaceutical product used to treat various neurological conditions. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 300 mg gabapentin capsules. The contract has a firm fixed price of $2,049.15 and a completion date of August 1, 2024. It is not a set-aside contract. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, which serve as primary vehicles for providing a wide range of...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ2VY
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4565442175 Gabapentin 800 mg tablets. The $2,527.06 firm-fixed-price contract has an estimated completion date of August 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/12/24, 9:01 AM